Should be worth a hell of a lot more in January when I assume they will outline their business development program to commence testing. They would not have been sitting idly just waiting for FDA approval. Management were very confident early on it appears.
Ann: HepaFat-AI gains US FDA clearance, page-109
Add RHT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.68M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29809 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable